Serbian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
Страна 1 од 18 резултати
Itacitinib in Advanced Hepatocellular Carcinoma
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
JAKaL is a single arm phase Ib study evaluating the effect of Itacitinib in 25 patients with advanced HCC.
Many patients diagnosed with HCC will have advanced disease where only palliative care is offered to them, this could account for the relatively low reported 5-year survival rate of
A Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Health Subject
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
This study will compare SN1011 with placebo. A placebo has no active drug in it. One group of participants will take SN1011 and another group will take the placebo. The effects seen in participants taking the study drug will be compared to the effects seen in participants who are taking the
ESTIMATION OF GINGIVAL CREVICULAR LEVEL OF YKL40
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Periodontal diseases is a chronic inflammatory diseases initiated by microbial infection that leads to a host response resulting in inflammatory breakdown of tooth supporting, osseous and soft tissue structures YKL-40 also called as human cartilage glycoprotein-39(HC-gp39), an acute phase protein is
Safety and Efficacy of Tofacitinib in the Treatment of NSAID Refractory Axial Spondyloarthritis:A Clinical Trial
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
INTRODUCTION Spondyloarthritis (SpA) is one of the most prevalent forms of chronic inflammatory arthritis. It affects approximately 0.01-2.5% in the World wide. Estimated prevalence of SpA in India is between 0.1 to 0.2% and prevalence in Bangladesh is about 1.2% .
Janus kinase (JAK) is a family of
Acalabrutinib, Venetoclax, and Obinutuzumab for Initial Therapy of CLL
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
This research study is a Phase II clinical trial. Phase II clinical trials test the safety and effectiveness of investigational drugs to learn whether the drugs work in treating a specific disease. "Investigational" means that the drugs are being studied. The FDA (the U.S. Food and Drug
Parkinsonian Brain Repair Using Human Stem Cells
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
This trial is a longitudinal, prospective, interventional, uncontrolled study designed to test, firstly, the safety and secondly, the potential efficacy of intraputaminal grafting of undifferentiated hfSC for the treatment of PD. Patients were monitored carefully for any adverse effects. All
Safety,PK/PD, Food Effect Study of Orally Administered HM71224 in Healthy Adult Male Volunteers
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Primary objective
- To evaluate the safety and tolerability, and if possible maximum tolerated dose (MTD) of HM71224 after single and multiple ascending dose administration in healthy subjects.
Secondary objective
- To determine the PK of HM71224 and selected metabolites (M1 and M2) following single
Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse Scleroderma
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Purpose:
Scleroderma is a connective tissue disease that is prototypical for fibrosis with autoantibodies and vascular abnormalities including vasomotor instability (Raynaud's) at one end and blood vessel obliteration at the other (1,2). Scleroderma occurs in > 2/10,000 (with thousands of Canadians
Differences in Bone Cell Activity Between Rheumatoid Arthritis and Ankylosing Spondylitis
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Objectives:
1. Assess the influence of immune system cells in the modulation of bone turnover in patients with RA, AS and healthy donors (Task 2).
2. Analyze the osteoclast precursors and their differentiation into fully functional osteoclasts in a subgroup of patients with RA, AS and healthy donors
The Immune and Clinical Impacts of Vitamin D in Patients With Chronic Musculo-skeletal Pain
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
The immune and clinical impacts of vitamin D in patients with chronic musculo-skeletal pain
Background Vitamin D is a group of fat-soluble secosteroids, the two major physiologically relevant forms are vitamin D2 (ergocalciferol) and vitamin D3 (cholecalciferol). Vitamin D without a subscript refers
Hydroxychloroquine With or Without Erlotinib in Advanced Non-small Cell Lung Cancer (NSCLC)
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
- The goal of this study is to find the highest dose of HCQ that can be given safely with erlotinib. Therefore, not all participants will receive the same dose of HCQ. Small groups of participants will be enrolled in steps in this trial. The first group will be given a certain dose of HCQ. If they
Erlotinib With or Without Hydroxychloroquine in Chemo-Naive Advanced NSCLC and (EGFR) Mutations
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
- Because no one knows which of the study options are best, participants will be randomized into of the study groups: Group A (erlotinib) or Group B (erlotinib and HCQ). Study treatment will be divided into time periods called cycles. Each study treatment cycle is 28 days.
- Erlotinib (Group A and
Fractalkine, a CX3C Chemokine, Act as a Mediator of Ocular Angiogenesis
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Fractalkine (FKN), the sole member of the CX3C chemokine family, is named for its fractal geometry. The CX3C motif, with three amino acids between the two terminal cysteines, makes fractalkine distinct from other chemokines.The structure of fractalkine, a membrane-bound glycoprotein with the
Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (Taski-3)
Само регистровани корисници могу преводити чланке
Пријави се / Пријави се
Најкомплетнија база лековитог биља подржана науком
- Ради на 55 језика
- Биљни лекови потпомогнути науком
- Препознавање биљака по слици
- Интерактивна ГПС мапа - означите биље на локацији (ускоро)
- Читајте научне публикације повезане са вашом претрагом
- Претражите лековито биље по њиховим ефектима
- Организујте своја интересовања и будите у току са истраживањем вести, клиничким испитивањима и патентима
Упишите симптом или болест и прочитајте о биљкама које би могле да помогну, укуцајте неку биљку и погледајте болести и симптоме против којих се користи.
* Све информације се заснивају на објављеним научним истраживањима
